Pfizer

Pfizer Inc and BioNTech SE have asked U.S. regulators to authorize emergency use of their COVID-19 vaccine for children ages 5 to 11, a group for whom no shot is currently allowed, Pfizer said on Oct. 7.

The Turkish Health Ministry's Science Board is currently working on plans as to when a third dose of the Pfizer/BioNTech's vaccine should start to be given to those who have already received two doses of the jab.

In 2022, adapted vaccines according to current variants of the coronavirus are expected to be approved. Currently, the third dose uses vaccines that we have, but a combination is allowed - in the first and second dose of vector vaccine to be given an mRNA vaccine.

It will be applied voluntarily to five groups of people

An order for the approval of a third booster dose of the Pfizer vaccine in Bulgaria is expected to be officially issued today. Yesterday, an expert council at the Ministry of Health approved the booster dose.

Prime Minister Florin Citu announced on Wednesday that a decision was made to start administering the third dose, starting with September 28, for all persons who have more than 6 months after the second dose, with any of the Pfizer BioNTech, Moderna and Astra Zeneca vaccines.

Pfizer initially turned down the offer of developing a coronavirus vaccine because its executives thought the virus would be rapidly contained, according to a report by the U.K.-based daily Telegraph.

The Expert Council on with the Ministry of Health advises against rushing the decision to have a booster dose of COVID-19 vaccines. The position of the expert council circulated by the Ministry of Health this morning after Health Minister Stoycho Katsarov yesterday said that a decision on a recommendation is pending at any moment from MA - the European Medicines Agency.

After former Prime Minister Boyko Borissov spoke about donating vaccines against COVID-19 in March and April, and the caretaker government continued talking in June decided on the donation in August, in September the procedure was completed by the Bulgarian institutions by a decision of the National Assembly on Wednesday (September 8).

A third dose of Pfizer Covid-19 vaccine has significantly improved protection from infection and serious illness among people aged 60 and older in Israel compared with those who received two shots, according to findings published by the Health Ministry and cited by Reuters. The full details of the study were not released.

A new study out of the UK has shown that the effectiveness of the Pfizer/BioNTech vaccine is waning faster than others when up against a high viral load mutation of the coronavirus, like the Delta variant